Lower extremity Flashcards
Highest bypass risk on duplex
PSV>300 or VR >3.5 or EDV >100
graft flow <45cm/sec
ABI reduction >0.15
high bypass risk on duplex
PSV >300 or Vr >3.5
graft flow >45 cm/sec
ABI reduction <0.15
Intermediate bypass risk on duplex
PSV 180-300 or Vr>2
graft flow >45 cm/sec
ABI reduction <0.15
low bypass risk on duplex
PSV <180
graft flow >45 cm/sec
ABI <0.15
definition of VR
PSV within lesion / PSV in proximal normal graft
acute lim ischemia class I
viable limb
no sensory or motor deficit
audible arterial and venous signal
acute limb ischemia class IIa
marginally threatened minimal sensory loss no motor loss inaudible arterial signal audible venous signal
acute limb ischemia class IIb
immediatelly threatened sensory loss more than toes + rest pain mild to moderate motor loss inaudible arterial signl audible venous signal
acute limb ischemia class III
irreversible
profound sensory loss
paralysis and rigor
inaudible arterial and venous signal
anterior lower leg compartment
tibialis anterior extensors peroneus tertium anterior tibial artery deep peroneal nerve
lateral lower leg compartment
peroneus longus and brevis
superficial peroneal nerve
superficial posterior lower leg compartment
gastrocnemius
soleus
plantaris
tibial nerve
deep posterior lower leg compartment
tibialis posterior
flexor popliteus muscle
anterior compartment of thigh
sartorius
quadriceps (rectus femoris, vastus lateralis, vastus medialis, vastus intermedius)
femoral nerve
posterior compartment of thigh
biceps
semimembranosus
semitendinosus
sciatic nerve
medial compartment of thigh
pectineus gracilis obturator externus adductor obturator nerve
L3 function
hip flexion
L4 function
knee extention
L5 function
foot dorsiflexion
2nd web space sensation
(injury causes foot drop)
S1 function
plantar flexion
Achilles reflex
lateral foot sensation
C5 function
deltoid and biceps
C6 function
biceps, weak wrist extention
C7 function
triceps
C8 function
intrinsic muscle of the hand
wrist flexion
arterial lysis Rochester trial
57 patients in urikinase and 57 patients in OR group
@ 1 year amp free: 75% vs 52%
arterial lysis STILE trial
393 patients -> surgery vs lysis with tPA and urokinase
If symptoms longer than 14 days –> amputation lower in OR (3vs 12%)
if symptoms shorter than 14 days –> amputation lower in lysis (11 vs 30%)
arterial lysis TOPAZ trial
better clinical outcomes in lysis group
what is 5 year patency of aorto - bifemoral bypass?
90%
what is 5 year patency of femorl - femoral bypass?
70%
what is 5 year patency of fem - BK pop bypass with vein?
70%
what is 5 year patency of iliac angioplasty?
70%
what is 5 year patency of axillary - bifemoral bypass?
70%
what is 5 year patency of ax-unifemoral bypass?
50-55%
what is 5 year patency of SFA patency for stenosis?
50-55%
what is 5 year patency of SFA angioplasty for occlusion?
40%
what is 5 year patency of fem - distal bypass?
40%
what is 5 year patency of of fem - BK pop with PTFE?
30%
what is a TASC A (Aorto - iliac)?
unilateral or bilateral stenosis of CIA
unilateral or bilateral single <= 3cm EIA stenosis
what is a TASC B (Aorto - iliac)?
<= 3cm stenosis of infrarenal aorta
unilateral CIA occlusion
stenosis 3-10cm involving EIA but not CFA
unilateral EIA occlusion (not CFA)